Advanced Enzyme Q1 FY27 Results: Revenue Rs 189 Cr, PAT Rs 38 Cr and Key Highlights
- August 10, 2026
- Posted by: Neeraj Pandey
- Category: News
Advanced Enzyme Q1 FY27 results declared August 8, 2026. Revenue Rs 189 Cr (+2.08% YoY). PAT Rs 38 Cr (-4.58% YoY). CMP Rs 324.35 (-1.65%).
Advanced Enzyme Q1 FY27 results were announced on August 8, 2026, consolidated. Revenue grew +2.08% YoY to Rs 189 Cr from Rs 185 Cr in Q1 FY26.
Operating profit stood at Rs 41 Cr (-12.24% YoY). PAT came in at Rs 38 Cr (-4.58% YoY), offering a comprehensive view of how Advanced Enzyme is navigating the current chemicals/biotech environment.
Click Here – Get Free Investment Predictions
Advanced Enzyme Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Cr) | Q1 FY26 (Rs Cr) | YoY Change |
|---|---|---|---|
| Advanced Enzyme Revenue | 189 | 185 | +2.08% |
| Operating Profit | 41 | 46 | -12.24% |
| Net Profit (PAT) | 38 | 40 | -4.58% |
| Reporting Basis | Consolidated | ||
Advanced Enzyme Q1 FY27 Performance Analysis
Check the Univest Screener for Live Data on This Stock
Advanced Enzyme Q1 FY27 results reflect modest fundamentals across key financial metrics. Revenue moderated slightly with the top line reaching Rs 189 Cr for the April to June 2026 quarter.
Operating profit contracted -12.24% YoY to Rs 41 Cr. Management is focused on cost rationalisation to restore operating leverage.
PAT of Rs 38 Cr marks a -4.58% YoY movement in Advanced Enzyme Q1 FY27 results. Investors monitoring Advanced Enzyme Q1 FY27 results will note this as a key FY27 performance milestone.
Key Business Factors in Advanced Enzyme Q1 FY27 Results
Revenue Expansion Driving Top-Line Growth
Advanced Enzyme Q1 FY27 results show top-line strength with revenue growing +2.08% YoY to Rs 189 Cr from Rs 185 Cr in Q1 FY26. Steady volume-led growth and disciplined pricing supported the revenue uptick.
Margin Pressure from Cost Headwinds
Operating profit in Advanced Enzyme Q1 FY27 results stood at Rs 41 Cr ((-12.24% YoY)), reflecting input cost inflation, wage pressures, and competitive pricing dynamics in the chemicals/biotech business.
PAT Performance and Profitability Trend
Net profit (PAT) in Advanced Enzyme Q1 FY27 results stood at Rs 38 Cr ((-4.58% YoY)). Near-term PAT moderation is being managed through cost optimisation and revenue diversification.
Dividend Details
No dividend was announced alongside Advanced Enzyme Q1 FY27 results. The company is likely channelling earnings toward business reinvestment and working capital needs.
FY27 Outlook for Advanced Enzyme
Following Advanced Enzyme Q1 FY27 results, management has reiterated a recovery-focused strategy targeting operational efficiencies, cost rationalisation, and revenue diversification. The pace of recovery in the chemicals/biotech segment will be a key monitorable for investors tracking Advanced Enzyme Q1 FY27 results. Consult a SEBI-registered financial advisor before making decisions.
Advanced Enzyme Stock Performance After Q1 FY27 Results
Download the Univest iOS App or Univest Android App to track Advanced Enzyme live price and get daily stock recommendations.
Advanced Enzyme shares were trading lower at Rs 324.35 (-1.65%) on August 8, 2026, reflecting investor sentiment on the Advanced Enzyme Q1 FY27 results and near-term sector outlook. The CMP of Rs 324.35 on the results date reflects broader market and sector sentiment in the chemicals/biotech space.
Key Risks for Advanced Enzyme
Sector-Specific Risks
Regulatory approvals and feedstock cost volatility are near-term concerns.
Valuation and Earnings Risk
Sustained earnings pressure may delay re-rating; near-term earnings visibility remains limited.
Operational and Financial Risk
Subsidiary-level losses or underperforming overseas operations could drag consolidated PAT lower.
Conclusion
Advanced Enzyme Q1 FY27 results reflect modest performance with revenue at Rs 189 Cr and PAT at Rs 38 Cr on a Consolidated basis. Operating leverage and sector tailwinds will determine the FY27 growth trajectory. Investors should review management commentary and sector developments before taking positions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Advanced Enzyme Q1 FY27 Results
When were Advanced Enzyme Q1 FY27 results declared?
Ans. Advanced Enzyme Q1 FY27 results were declared on August 8, 2026, covering the April to June 2026 quarter on a Consolidated basis.
What was Advanced Enzyme revenue in Q1 FY27?
Ans. Advanced Enzyme Q1 FY27 results show revenue of Rs 189 Cr, +2.08% compared to Rs 185 Cr in Q1 FY26.
What was Advanced Enzyme PAT in Q1 FY27?
Ans. Net profit in Advanced Enzyme Q1 FY27 results was Rs 38 Cr, -4.58% year-on-year.
Did Advanced Enzyme declare a dividend in Q1 FY27?
Ans. No dividend was announced alongside Advanced Enzyme Q1 FY27 results. Check the official NSE and BSE announcements for future dividend declarations.
What is the FY27 outlook for Advanced Enzyme?
Ans. Management has guided operational restructuring and return to profitability for FY27. Sector trends and order visibility will be key monitorables for investors.
How did Advanced Enzyme stock react to Q1 FY27 results?
Ans. Advanced Enzyme shares were trading lower at Rs 324.35 (-1.65%) on August 8, 2026 following the Advanced Enzyme Q1 FY27 results. Always consult a SEBI-registered financial advisor before acting on stock price movements.
